Yehuda Carmeli

Public Health, Environmental and Occupational Health · 2000–2019

A researcher in the Science corpus: 13 papers; trusts 3 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

• Public Health, Environmental and Occupational Health — 14 citations into it; #1,968 of 2,368 by trust here, #609 by citations
• Surgery — 11 citations into it

Whom Yehuda Carmeli trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Sterne
2. S. Cosgrove
3. Matthias Egger

Who trusts Yehuda Carmeli overall

1. S. Cosgrove
2. T. Dellit

Papers from Yehuda Carmeli's perspective

Ordered by how strongly the researchers Yehuda Carmeli trusts endorse each paper. Same corpus, a different order for every researcher.

1. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
2. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (Clinical Infectious Diseases)
3. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. (Clinical Infectious Diseases)
4. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. (Journal of Clinical Epidemiology)
5. The impact of antimicrobial resistance on health and economic outcomes. (Clinical Infectious Diseases)
6. Metallo-β-Lactamases: the Quiet before the Storm? (Clinical Microbiology Reviews)
7. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. (Clinical Infectious Diseases)
8. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (Clinical Infectious Diseases)
9. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
10. Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)

Their papers

• Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread (2019) — 678 citations
• Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2017) — 4,785 citations
• The negative impact of antibiotic resistance. (2016) — 758 citations
• Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. (2012) — 883 citations
• Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (2012) — 13,127 citations
• Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. (2007) — 652 citations
• Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli (2007) — 598 citations
• Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact (2006) — 657 citations
• The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges (2005) — 994 citations
• Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. (2003) — 2,158 citations
• Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (2003) — 1,024 citations
• The impact of antimicrobial resistance on health and economic outcomes. (2003) — 635 citations
• Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. (2000) — 600 citations